SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending after announcing its oral obesity drug, VK2735, will advance directly to Phase 3 trials in Q3 2026, significantly accelerating its market timeline and drawing community discussion around its strong clinical pipeline. This accelerated development, coupled with ongoing Phase 3 trials for its injectable version and a robust cash position, fuels community sentiment that the company is undervalued and a prime acquisition target, especially amid recent regulatory scrutiny on compounded GLP-1 alternatives.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is heavily trending ahead of its imminent earnings report, as the community eagerly anticipates results that could drive significant volatility or a "buy the dip" opportunity, given its strategic role in the burgeoning AI infrastructure market and recent acquisition in agentic AI search.

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

NovoCure is trending due to recent FDA approval of its Optune Pax wearable device for locally advanced pancreatic cancer, marking the first new therapy in decades for this indication. The community is actively debating its potential for a significant price run and short squeeze, while others express caution regarding historical volatility in biopharma approvals and the practical impact of the reported survival benefits.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending due to the impending shareholder vote to merge with Infleqtion, a quantum technology leader that recently secured high-profile contracts with NASA for space sensing and the U.S. Department of Energy for energy grid optimization. The community is actively debating Infleqtion's significant undervaluation compared to its peers and its robust real-world applications, though some express caution given the SPAC sponsor's past performance.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management system, as well as other tools, integrations and native payment solutions. It operates through the following geographical segments: Americas, Europe and Asia Pacific. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot is trending following its strong Q4 earnings, beat-and-raise guidance, and new $1 billion share buyback, yet the stock is experiencing a sharp sell-off, prompting intense community debate over whether analyst price target cuts and pervasive "AI disruption" fears are unjustly punishing the SaaS sector.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is trending after its Q2 earnings report, which initially caused a stock dip due to a gross margin miss and merely meeting guidance; however, robust AI infrastructure order growth and a raised full-year outlook are now fueling a rally, sparking widespread community discussion about the company's AI-driven future and its position near historic dot-com era highs.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending following better-than-expected revenue growth, an optimistic outlook, and the authorization of a significant share repurchase program, drawing multiple analyst upgrades. Despite strong underlying fundamentals, the stock experienced extreme volatility and a notable pullback, leading to community discussions centered on "buying the dip" amid theories of market manipulation and the impact of a slight earnings per share miss.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is soaring following unexpectedly strong earnings, delivering record revenue, improved profitability, and positive cash flow, with the community actively discussing its robust security growth and AI tailwinds as key drivers for a potential sustained turnaround.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape's new Eagle Line pilot production facility and ongoing B-sample shipments to automotive OEMs are sparking intense community discussion. Investors are actively debating the company's path to commercialization and eagerly anticipating concrete partnership announcements for its solid-state battery technology.

SOLV Energy, Inc. Class A Common Stock

MWH, a recent IPO, is trending as the community highlights its strong revenue growth, profitability, and substantial backlog from utility-scale solar and battery storage EPC contracts, positioning it as a compelling play in renewable energy infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IXHL + $RMD ….the timing and fit line up perfectly 

Incannex has taken IHL-42X as far as it needs to go to prove value. Phase 2 de-risked, Phase 3 urgent, and funding with RS and further dilution was never part of Joel’s plan.
ResMed doesn’t have a pharma arm, but OSA is their core business. Acquiring IXHL skips years of development, blocks competitors, and drops a differentiated pill straight into their ecosystem

Richard Sultana

LazySoo

Raphael

Joseph Greer

Damien Keys

James B Long

John Meyer

Timm Belcher

luigi

Dave

katie

$IXHL “ they don’t have a pharma arm” oh no biggie 🙄 it’s easier for them to just shelf it then commercialize it

StockTwits for iOS

Dr Anna

Ernesto

Incannex Healthcare Limited - ADR

Resmed Inc.

 ….the timing and fit line up perfectly 

Incannex has taken IHL-42X as far as it needs to go to prove value. Phase 2 de-risked, Phase 3 urgent, and funding with RS and further dilution was never part of Joel’s plan.
ResMed doesn’t have a pharma arm, but OSA is their core business. Acquiring IXHL skips years of development, blocks competitors, and drops a differentiated pill straight into their ecosystem

ORIX Corp.

Intelsat S.A

@Rvvrn9 still think its the  area of metabolic disease illnesses that wants this.+ 80%crossover with T2D and obesity pluss a non obese non cpap suitable stand alone , plus a diagnosed cpap population already as a co therapy

StockTwits For Android 

 still think its the  area of metabolic disease illnesses that wants this.+ 80%crossover with T2D and obesity pluss a non obese non cpap suitable stand alone , plus a diagnosed cpap population already as a co therapy